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Edited by Masayuki MiyasakaAbstract The membrane associated RING-CH (MARCH)
family of genes encode a novel group of RING-type ubiquitin
E3 ligases. Overexpression of one of these family members,
MARCH-IX, leads to a downregulation of cell surface major
histocompatibility complex (MHC) class I and CD4. Here, we
identify MARCH-IX as the ﬁrst ubiquitin E3 ligase to control
expression of the critical cell adhesion molecule ICAM-1.
MARCH-IX expression causes ubiquitination and downregu-
lation of ICAM-1 and a short alternative transcript of
MARCH-IX lacking the RING-CH domain, termed
MARCH-IX RINGless, is shown to act as a positive regulator
of MARCH-IX activity.
 2006 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Ubiquitination is an important mechanism for regulating the
cell surface expression of an increasing number of immunore-
ceptors and may result in proteasomal or lysosomal destruc-
tion of the targeted protein [1]. The attachment of ubiquitin
is a stepwise process involving the initial binding of ubiquitin
by the E1 activating enzyme, transfer of activated ubiquitin
to an E2 conjugating enzyme and attachment of ubiquitin to
the substrate. The last step is regulated by a number of diﬀer-
ent E3 ubiquitin ligases which associate with the speciﬁc sub-
strate. There are two main families of E3 ligases, containing
either a HECT or a RING domain which binds the E2 enzyme.
RING-CH proteins are a subgroup of the RING family, and
were initially described following the identiﬁcation of the K3
family of viral E3 ligases in c-herpesviruses (reviewed in [2]).
The founding members, K3 and K5 from Kaposi’s sarcoma-
associated herpesvirus (KSHV) and mK3 from the related
murine c-herpesvirus 68 (MHV68) decrease expression of ma-
jor histocompatibility complex (MHC) class I molecules [3–5]
and K5 was subsequently shown to have a broader speciﬁcity,
downregulating HLA-A and -B, B7.2, PECAM and intercellu-
lar adhesion molecule (ICAM-1) [6–8]. The zinc-binding struc-Abbreviations: ICAM, intercellular adhesion molecule; RING, really
interesting new gene; MARCH, membrane associated RING-CH;
MHC, major histocompatibility complex; TGN, trans-Golgi network
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being initially described as a PHD domain, the solution struc-
ture of the K3 zinc-binding domain subsequently proved it to
be a member of the RING family [9], and it was therefore
named the RING-CH domain.
Viruses are well recognised to pirate genes from their hosts,
and ten mammalian gene products containing the novel
RING-CH domain have been identiﬁed [2,10]. While showing
little sequence homology with the viral E3 ligases, these mam-
malian orthologues share a similar structural organization – a
RING-CH domain and two or more transmembrane seg-
ments. These cellular homologues have been named the
MARCH (membrane associated RING-CH) family of pro-
teins [10] with only MARCH-VII and -X not predicted to be
integral membrane proteins.
Other than E3 ligase activity, little is known about the func-
tion or substrates of the MARCH gene products (reviewed in
[2]). MARCH-II and -III localise to endosomes and interact
with each other and syntaxin 6, a SNARE protein involved
in vesicle fusion [11], leading to a suggested role in vesicle traf-
ﬁcking. Overexpressed MARCH proteins downregulate a vari-
ety of immunoreceptors, including MHC I and II, CD4, CD86,
Fas and the transferrin receptor [10–13]. The closely related
MARCH-IV and -IX downregulate both MHC class I and
CD4 molecules [10].
ICAM-1, an important substrate of K5, is a widely ex-
pressed adhesion molecule which binds the LFA-1 integrin
and plays a critical role in the formation of the immunological
synapse during T cell activation and trans-endothelial migra-
tion of activated lymphocytes [14]. Low level ICAM-1 on tu-
mours is associated with more aggressive disease [15].
ICAM-1 transmits a co-stimulatory signal in T and B cells
and ICAM-1 deﬁcient mice show an impaired immune re-
sponse [16].
In this report, we identify ICAM-1 as an additional
MARCH-IX substrate, and show that a naturally occurring
MARCH-IX alternate transcript, ‘MARCH-IX RINGless’,
potentiates the functional activity of MARCH-IX by enhanc-
ing its expression.2. Materials and methods
2.1. Antibodies
The antibodies used were APC-conjugated anti-ICAM-1 (HA58)
(BD bioscience), anti-FLAG M2 aﬃnity gel, biotinylated or puriﬁed
M2 anti-FLAG (Sigma), anti-myc (9B11) (CST), rabbit-anti-myc
(A14) (Serotec), anti-HA.11 (Covance), anti-Cathepsin D (A0561)
(Dako), anti-TGN 46 (AHP500G) (Serotec), Cy5-conjugated anti-
mouse Ig (Jackson ImmunoResearch), anti-rabbit 568 and anti-sheep
594 (Molecular Probes). Anti-MHC class I (W6/32) was a hybridoma
supernatant.blished by Elsevier B.V. All rights reserved.
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GFP fusion constructs were made in pEGFP (Clontech). The GFP-
K3 construct was a kind gift from Eric Hewitt. pMSCV-puro (Clon-
tech) was used for retroviral transductions or transient transfectionsA
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Fig. 1. MARCH-IX ubiquitinates and downregulates ICAM-1. (A) Cytoﬂu
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myc-tagged ICAM-1 were expressed in 293T cells in the combinations
11) the proteins were separated by SDS–PAGE and membranes probed
el) and the same membrane probed with the HA-antibody to detect
S. Hoer et al. / FEBS Letters 581 (2007) 45–51 47directed mutagenesis was performed with the QuickChange method
(Stratagene). IMAGE clone 4811410 encodes MARCH-IX, clone
3936171 MARCH-IX RINGless.
2.3. Cells and transfections
HeLa and 293T cells were grown in DMEM (Invitrogen) supple-
mented with 10% foetal calf serum and antibiotics. 293T ICAM cells
were generated by retroviral transduction. TransIT293 and HeLa
Monster (Mirus) transfection reagents were used.
2.4. Confocal microscopy
Immunoﬂuorescence staining was analysed on a Zeiss LSM510
META Confocal Microscope.
2.5. Retroviral transductions
Retroviral transductions were performed as previously described
[17].
2.6. Flow cytometry
Flow cytometry was performed as previously described [17].
2.7. RNAi
RNA duplexes (Dharmacon) speciﬁc for the target sequence
UGUGAGCUCUGCUACUUCA were used to deplete MARCH-IX
mRNA. The control oligo targeted an intronic sequence from the same
locus (GAAGACAGAUGUUGAUCCU). RNAi depletion was as
previously described [17].
2.8. Immunoprecipitation and immunoblot
Cells were lysed in either 1% Triton X-100 or 1% Digitonin (Calbio-
chem) in PBS for 45 min on ice and the lysate pre-cleared with CL-4B
sepharose (Sigma) for 1 h at 4 C. Anti-FLAG M2 Aﬃnity Gel was
used to precipitate FLAG-tagged proteins for 1hr at 4 C. Streptavi-
din-agarose (Sigma) was used for precipitation of SBP-tagged proteins.
The precipitates were eluted in SDS sample buﬀer, separated on poly-
acrylamide gels and transferred to PVDF membranes (Millipore). To
detect FLAG-tagged proteins the membrane was probed with biotinyl-
ated M2 anti-FLAG antibody and a streptavidin-HRP conjugate
(ExtrAvidin, Sigma). TrueBlot (ebioscience) was used to detect mouse
antibodies. Goat anti-rabbit Ig HRP conjugated (Jackson) was used to
detect rabbit antibodies. ECL detection reagents were from Amer-
sham.Fig. 2. MARCH-IX is localised to lysosomes. HeLa cells transiently tran
(lysosomes) or TGN46 (TGN) 24 h post transfection.3. Results and discussion
3.1. ICAM-1 is a new target of MARCH-IX
MARCH-IX downregulates cell surface MHC class I and
CD4 [10]. Since the related K5 viral protein downregulates sev-
eral cell surface immunoreceptors, including ICAM-1 (CD54),
we examined whether MARCH-IX also downregulates
ICAM-1. A MARCH-IX-GFP fusion construct allowed us
to compare MARCH-IX expression, as determined by GFP
levels, with the downregulation of target proteins by ﬂow
cytometry (Fig. 1). The introduction of MARCH-IX cDNA
into a stable 293T cell line expressing ICAM-1 resulted in eﬃ-
cient downregulation of cell surface ICAM-1 (Fig. 1A). The ef-
fect was similar to GFP-K5, while GFP-K3 had no eﬀect on
ICAM-1 levels, but downregulated MHC class I molecules.
To conﬁrm that the downregulation of ICAM-1 is due to
MARCH-IX, we showed that the decreased ICAM-1 expres-
sion in a stable MARCH-IX expressing HeLa cell line
(Fig. 1B, left panel) was restored by siRNA-mediated deple-
tion of MARCH-IX, an eﬀect not seen with the control siRNA
(Fig. 1B, right panel).
3.2. MARCH-IX ubiquitinates ICAM-1
ICAM-1 has ﬁve lysine residues in its cytoplasmic tail, each
of which could serve as an ubiquitin acceptor. To determine
whether ubiquitination is responsible for the MARCH-IX-in-
duced downregulation of ICAM-1, we expressed myc/GFP-
tagged ICAM-1 together with HA-tagged ubiquitin and
MARCH-IX in ICAM-1-deﬁcient 293T cells. As a control
we used an identical, tagged ICAM-1 construct in which all
ﬁve of the lysines in the cytoplasmic tail of ICAM-1 were mu-
tated to arginines (ICAM-1-DK). As shown (Fig 1C), wildtype
ICAM-1 is eﬀectively downregulated by MARCH-IX, while
lysine-depleted ICAM-1-DK is resistant to MARCH-IX.
MHC class I molecules were still downregulated in these cells
(data not shown). Immunoprecipitation of ICAM-1 andsfected with MARCH-IX-GFP were stained for either Cathepsin D
48 S. Hoer et al. / FEBS Letters 581 (2007) 45–51immunoblotting for HA-ubiquitin revealed that expression of
MARCH-IX causes ubiquitination of wildtype ICAM-1 but
not the lysine-less mutant (ICAM-1-DK) (Fig. 1D, right panel,
lane 6 vs 7). The ubiquitinated ICAM-1 proteins gained
approximately 10 kDa, as determined from the SDS–PAGE
gel. Since ubiquitin is 8 kDa, this result suggests that mono-
ubiquitination of ICAM-1 by MARCH-IX is suﬃcient for
downregulation.
3.3. MARCH-IX is localised in lysosomes
To identify the subcellular localisation of MARCH-IX we
transiently transfected HeLa cells with a GFP-MARCH-IX fu-
sion construct and 24 h post transfection stained for TGN46 (a
marker of the trans-Golgi network) or Cathepsin D (a lyso-
somal marker) and analysed samples by confocal microscopy.I IIA
B
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Fig. 3. The MARCH-IX RINGless alternative transcript is non-functional. (
RINGless. Full length (accession number BC050397.1) and MARCH-IX RIN
locus (LOC92979). The MARCH-IX RINGless alternative transcript starts
domain is encoded by exons I and II, the two transmembrane regions are
encoding 57 amino acids, is depicted as diagonal stripes. (B) MARCH-IX am
highlighted in italics, the RING-CH domain is bold, and the transmembrane
region highlighted. The asterisk indicates the start of the region shared with
Cytoﬂuorometric analysis of ICAM-1 and MHC class I expression in 293T IC
1), MARCH-IX RINGless (MARCH-IXDR – column 2), MARCH-IX la
MARCH-IX aspartate to asparagine mutant (MARCH-IXD/N – column 4)
encoding plasmid.The majority of cells displayed a punctate vesicular staining
that co-localised predominantly with lysosomal markers
(Fig. 2). In contrast to the published data, the only co-localisa-
tion of MARCH-IX with the trans-Golgi network (TGN) was
seen in cells heavily overexpressing MARCH-IX.
3.4. MARCH-IX RINGless is an alternative transcript of
MARCH-IX
The MARCH-IX locus appears unique among the MARCH
genes as it encodes two alternative transcripts. Transcript ini-
tiation upstream of exon 1 results in full length MARCH-
IX, while an alternate transcript initiated upstream of exon 3
encodes a shortened MARCH-IX which we called MARCH-
IX RINGless. MARCH-IX RINGless has a unique N-termi-
nus of 57 amino acids, followed by identical transmembraneIII IV
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S. Hoer et al. / FEBS Letters 581 (2007) 45–51 49regions and C-terminus as full length MARCH-IX (Fig. 3).
Like all RING type E3 ligases the RING-CH domain is essen-
tial for binding the E2 ubiquitin-conjugating enzyme [17,18].
Mutations within this domain therefore lead to a loss of ubiq-
uitination of the target protein [17,18]. As predicted, expres-
sion of MARCH-IX RINGless was unable to downregulate
MHC class I or ICAM-1 (Fig. 3C).A
B
Cl
as
s 
I
MARCH-IX/GFP
IC
AM
1
293T
HeLa
MARCH-IX
MARCH-IXΔR
1
0 2
1
MARCH-IX
MARCH-IXΔR
1
0 1
1
MARCH-IX/GFP
C
36
50
36
50
IP: FLAG
IB: Bio-FLAG
IP: FLAG
IB: Bio-FLAG
293T
HeLa
MARCH-IX
MARCH-IXΔR
1
0 1 2 3
1 1 1
0
0
MARCH-IX
MARCH-IXΔR
1
0 2 4
7
0
1 1
0
0
10 10 10 10 10
10
10
10
10
10
10
10
10
10
10
42.6 50.8
8.8 11.4
Ratio
Ratio
10 10 10 10 10 10
10
10
10
10
10
10
10
10
10
10
10
10 10 10 10 10
10
10
10
10
10
10 10 10 10 10
10
10
10
10
10
Fig. 4. MARCH-IX RINGless enhances the function of full length MARCH
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a bicistronic vector also encoding GFP. The percentage of GFP positive c
transfection. (C) RINGless MARCH-IX stabilizes full length MARCH-IX.
transfected with a ﬁxed quantity of full length, FLAG-tagged MARCH-
MARCH-IX RINGless (M-IXDR), as in (B). Following 1% Triton X-100 ex
separated by 10% SDS–PAGE, transferred to Immobilon-P membranes and
were used as for the FACS analysis, with equal cell equivalents loaded in ea3.5. A charged residue in the MARCH-IX transmembrane
region is required for maximal activity
Other than the RING-CH domain and TM region,
MARCH-IX has no additional structural domains. Having
demonstrated an essential functional role for the RING-CH
domain, we made further mutations to examine other
potentially important regions of the protein. Deletion of a4 6
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probed with biotinylated M2 anti-FLAG antibody. The identical cells
ch lane.
50 S. Hoer et al. / FEBS Letters 581 (2007) 45–51proline-rich domain in the N-terminus with a potential WW
domain-binding motif (PPLP, Fig. 3B) did not eﬀect
MARCH-IX’s ability to down regulate MHC class I
(Fig. 3C). The transmembrane regions of the K3 and K5 E3
ligases are required for target recognition [19] and MARCH-
IX has a charged aspartate residue in its second transmem-
brane domain which is of potential importance for substrate
binding. Charged residues within the transmembrane region
are essential for the assembly of protein complexes like the
T-cell and NKG2D receptor [20]. Mutation of the aspartate
residue to asparagine reduced MARCH-IX’s ability to down-
regulate MHC class I molecules, with only a minor eﬀect on
ICAM-1 downregulation. The charged residue in the trans-
membrane region may therefore be required for MARCH-IX
function against some targets.
3.6. MARCH-IX RINGless augments MARCH-IX function
Sanchez et al. reported that overexpression of a K5 deletion
construct lacking the RING-CH domain was non-functional
and acted as a dominant negative mutant to inhibit full-length
K5 [19]. We therefore predicted that MARCH-IX RINGless
would be a negative regulator of full length MARCH-IX. To
test this hypothesis 293T and HeLa cells were transfected with
a ﬁxed quantity of full-length, epitope-tagged MARCH-IX
cDNA and increasing concentrations of epitope-tagged
MARCH-IX RINGless cDNA. Importantly, each reaction
was supplemented with empty vector to ensure the same total
amount of DNA was transfected. A bicistronic vector encod-
ing both MARCH-IX and GFP provided an indirect measure
of MARCH-IX expression levels. Rather than inhibiting
MARCH-IX function, co-transfection of increasing amounts
of MARCH-IX RINGless cDNA enhanced MARCH-IX
activity and led to a further decrease in cell surface expression
of MHC class I molecules (Fig. 4A). The downregulation was
quantiﬁed by determining the percentage of GFP positive cells
with downregulated MHC class I at a ﬁxed concentration of
MARCH IX and increasing concentrations of MARCH-IX+
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tagged proteins, following SBP precipitation in lane 1 of each panel, was ver
background bands are marked with an asterisk.RINGless. This increased from 43% with MARCH-IX alone
to 68% in cells co-expressing the highest concentration of
MARCH-X RINGless. Enhanced down-regulation of MHC
class I molecules could also be achieved by increasing the
quantity of MARCH-IX cDNA, with concomitant higher
GFP levels (Fig. 4A, 7 + 0). A similar eﬀect was seen
for ICAM-1 in HeLa cells. Increasing concentrations of
MARCH-IX RINGless enhanced the downregulation of
ICAM-1. The eﬀect was less pronounced than for MHC class
I due to a reduced transfection eﬃciency in HeLa versus 293T
cells. The proportion of transfected cells downregulating
ICAM-1 rose from 8.8% in cells expressing MARCH-IX alone
(Fig. 4B, 1 + 0) to 23.7% in cells co-expressing high levels of
MARCH-IX RINGless (Fig. 4B, 1 + 6).
3.7. MARCH-IX RINGless enhances MARCH-IX expression
To determine how MARCH-IX RINGless aﬀects full-length
MARCH-IX expression, we immunoprecipitated both pro-
teins from cell lysates with the FLAG-speciﬁc antibody and
after separation by SDS–PAGE, visualised both proteins with
biotinylated anti-FLAG antibody. In both cell types, increased
expression of MARCH-IX RINGless (M-IXDR) led to a
marked increase in detectable full length MARCH-IX
(Fig. 4C).
3.8. MARCH-IX heterodimerises with MARCH-IX RINGless
The increased expression of MARCH-IX in the presence of
MARCH-IX RINGless suggested a direct interaction between
the two proteins and we therefore looked for homo- or hetero-
dimerisation. We used fusion constructs of MARCH-IX or
MARCH-IX RINGless with the streptavidin binding peptide
(SBP) tag, a 45 amino acid tag with high aﬃnity for streptavi-
din which allows for eﬃcient streptavidin-agarose precipita-
tion. All transiently transfected proteins also carried a
FLAG tag. To better distinguish SBP-tagged from untagged
MARCH-IX by size separation, a GFP fusion construct was
used (Fig. 5 schematic). SBP-tagged MARCH-IX still down-FP
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-IXΔR
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imers. RINGless and full length MARCH-IX fused to a tandem SBP
with FLAG-tagged RINGless or full length MARCH-IX in 293T cells.
cipitated with streptavidin-agarose, separated by 10% SDS–PAGE,
tibody. As all constructs are FLAG-tagged, the intensity of the SBP-
y strong, causing bands to appear ‘white’ and not ‘black’. Unidentiﬁed
S. Hoer et al. / FEBS Letters 581 (2007) 45–51 51regulated MHC class I and ICAM-1, and was enhanced
by SBP-MARCH-IX RINGless (data not shown). SBP-
MARCH-IX RINGless co-precipitated MARCH-IX RING-
less and full length MARCH-IX-GFP. SBP-MARCH-IX
coprecipitated MARCH-IX RINGless and MARCH-IX-GFP.
As the SBP-tagged and also the co-precipitated protein carry
a FLAG tag, they were both detected with the FLAG-speciﬁc
immunoblot. Taken together these results show that full length
MARCH-IX both homodimerises and is able to form hetero-
dimers with MARCH-IX RINGless.
We have therefore identiﬁed MARCH-IX as the ﬁrst cellular
E3 ligase to ubiquitinate and downregulate ICAM-1 from
the cell surface. Confocal microscopy revealed that under
steady-state conditions GFP-tagged MARCH-IX is localised
to lysosomes, supporting a potential role in endocytosis.
MARCH-IX is expressed at elevated levels in tissues of T
and B cell origin and also in dendritic cells [21], all of which
are functionally dependent on ICAM-1 expression. Whether
MARCH-IX inﬂuences ICAM-1 levels in vivo is under inves-
tigation. The identiﬁcation of MARCH-IX RINGless as a
positive regulator of MARCH-IX, enhancing the MARCH-
IX-mediated downregulation of MHC I and ICAM-1 was
unexpected. MARCH-IX RINGless forms heterodimers with
MARCH-IX, which appear to potentiate function by stabi-
lizing the full length protein. Future eﬀorts will focus on
identifying further substrates of MARCH-IX, and the physio-
logical role of this protein in vivo.
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